PULMONX CORPORATION Proceeds from Long-Term Debt Issued
PULMONX CORPORATION (LUNG) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2025-02-25
- PULMONX CORPORATION proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $0.00.
- PULMONX CORPORATION proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was $0.00.
- PULMONX CORPORATION proceeds from issuance of long-term debt for the quarter ending 2024-06-30 was $0.00.
- PULMONX CORPORATION proceeds from issuance of long-term debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION proceeds from issuance of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PULMONX CORPORATION proceeds from issuance of long-term debt for fiscal 2023 was $20.00M.
- PULMONX CORPORATION proceeds from issuance of long-term debt for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $0.00 derived: sum of 2 quarters · filed 2024-11-01 | $0.00 10-Q · filed 2024-11-01 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $0.00 10-Q · filed 2024-08-02 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $20.00M 10-K · filed 2025-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $0.00 derived: sum of 2 quarters · filed 2024-11-01 | $20.00M 10-Q · filed 2024-11-01 | $20.00M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $20.00M 10-Q · filed 2024-08-02 | $20.00M derived: sum of 3 quarters · filed 2024-08-02 | $20.00M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $20.00M 10-Q · filed 2024-05-03 | $20.00M derived: sum of 2 quarters · filed 2024-05-03 | $20.00M derived: sum of 3 quarters · filed 2024-05-03 | $20.00M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |